Back to the news list
17 March 2020

Our factories are open

In the current context of a pandemic, strict confinement measures have been given in France and certain countries. We want to reassure you about the continuity of our business and our ability to meet your needs of isothermal solutions for the transport of medicines.

As a supplier and partner to many pharmaceutical companies, we shall continue our activity while strengt

hening the hygiene and health measures recommended to protect our staff.

Today we have sufficient stock of raw materials and finished products, on-going supplies, available carriers and production teams fully mobilized to meet your needs.

Our 8 production sites are operational on 4 continents: USA (Philadelphia), Brazil (Sao Paolo), France (St Georges de Reneins), UK (Leigh-on-Sea), Germany (Neunkirchen), India (Bangalore), China (Shanghai) and Singapore.

Our sales teams can be reached by email and phone.

The unprecedented situation in which we find ourselves nevertheless leads us to be cautious and we will keep you informed in case of change.

Other news

21 October 2024

 Proud to be featured in the latest edition of World Pharmaceutical Frontiers magazine!

In an Q&A,  Bob McClain, Americas Regional Sales Director, reveals how EMBALL'ISO is revolutionizing pharmaceutical transport through our innovative lightweight, reusable isothermal packaging solutions.
Read more
28 August 2024

EMBALL'ISO participates in Logipharma US 2024

We look forward to seeing you at Logipharma US 2024! Let's network and discuss how we can help your cold chain logistics.
Read more
18 June 2024

Meet us at INTERPHEX JAPAN 2024

MBALL`ISO Japan will participate to INTERPHEX Japan 2024 (26th -28th June 2024) at Tokyo Big Site. Our booth will be located at #40-33 in East-5 Hall.
Read more
14 May 2024

EMBALL'ISO is now established in Australia and New Zealand with a subsidiary

EMBALL’ISO is ready to start its full operation in Australia and New Zealand following the establishment of its subsidiary EMBALL'ISO Australia in 2023.
Read more